Zdrowie i gospodarka · 07/01/2004

FDA Releases Draft Guidance for Industry on Drug Substance Chemistry, Manufacturing, and Controls Information

The Food and Drug Administration (FDA) has made available a draft guidance document outlining recommendations for the chemistry, manufacturing, and controls (CMC) information required for drug substances to support new drug applications, including original NDAs and ANDAs.